Sisram Medical (HKSE:01696) Ending Cash Position : HK$473 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Sisram Medical Ending Cash Position?

Sisram Medical's Ending Cash Position for the quarter that ended in Dec. 2023 was HK$473 Mil.

Sisram Medical's quarterly Ending Cash Position declined from Dec. 2022 (HK$582 Mil) to Jun. 2023 (HK$407 Mil) but then increased from Jun. 2023 (HK$407 Mil) to Dec. 2023 (HK$473 Mil).

Sisram Medical's annual Ending Cash Position declined from Dec. 2021 (HK$974 Mil) to Dec. 2022 (HK$582 Mil) and declined from Dec. 2022 (HK$582 Mil) to Dec. 2023 (HK$473 Mil).

Sisram Medical Ending Cash Position Historical Data

The historical data trend for Sisram Medical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sisram Medical Ending Cash Position Chart

Sisram Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

778.38

646.30

974.25

582.29

472.77

Sisram Medical Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial													974.25	1,101.07	582.29	406.54	472.77

Sisram Medical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sisram Medical's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	584.118	+	-111.352
	=	473

Sisram Medical's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	405.337	+	67.429
	=	473

Sisram Medical Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Sisram Medical's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Sisram Medical (HKSE:01696) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sisram Medical Ltd (HKSE:01696) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895

Website

https://www.sisram-medical.com

Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.

Executives

Fosun Holdings Limited
Fosun International Holdings Ltd.
Fosun International Limited
Guo Guangchang
Ample Up Limited
Fosun Industrial Co., Limited
Shanghai Fosun High Technology (group) Co., Ltd.
Shanghai Fosun Pharmaceutical (group) Co., Ltd.
Chindex Medical Limited

Sisram Medical (HKSE:01696) Headlines

No Headlines